Durable Efficacy and Manageable Safety in Patients Aged ≥75 Years With Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL) Treated With Tisagenlecleucel in the Real-World Setting Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Landsburg, Daniel J
  • Heim, Michael
  • Moskop, Amy
  • Foley, Ronan
  • Hill, Brian T
  • Schofield, Grant
  • Jacobson, Caron A
  • Jaglowski, Samantha
  • Locke, Frederick L
  • Ram, Ron
  • Riedell, Peter A
  • Shah, Gunjan L
  • Popplewell, Leslie L
  • Tiwari, Ranjan
  • Lim, Stephen
  • Maier, Harald
  • Majdan, Marta
  • Pasquini, Marcelo C
  • Frigault, Matthew J

publication date

  • September 2024